Global Information
회사소개 | 문의 | 비교리스트

바이러스 여과 제품

Virus Filtration Products

리서치사 Global Industry Analysts, Inc.
발행일 2022년 01월 상품 코드 939792
페이지 정보 영문 335 Pages
가격
US $ 4,950 ₩ 6,017,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 18,051,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



바이러스 여과 제품 Virus Filtration Products
발행일 : 2022년 01월 페이지 정보 : 영문 335 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

COVID-19의 위기와 다가오는 경제 불황에서 세계의 바이러스 여과 제품 시장은 예측 기간 중 13.6%의 CAGR로 성장할 전망입니다. 키트 & 시약 부문은 14.7% 이상의 성장이 전망되며, 예측 기간말까지 36억 달러에 달할 것으로 예측되고 있습니다. 새로운 시나리오에서는 미국의 CAGR이 12.9%로 수정되어 있습니다. 독일은 향후 7-8년간 1억 2220만 달러를 넘는 시장 규모의 확대가 예측됩니다. 일본의 키트 & 시약 부문은 예측 기간말까지 2억 1820만 달러에 달할 전망입니다.

조사 대상 기업의 예

  • Asahi Kasei Medical Co., Ltd.; Charles River Laboratories International, Inc.; General Electric Company; Lonza Group AG; Merck KgaA; MilliporeSigma; Pall Corporation; Sartorius AG; Thermo Fisher Scientific, Inc.

세계의 바이러스 여과 제품 시장에 대해 조사했으며, 시장의 개요, COVID-19가 미치는 영향, 지역·국가별 분석과 예측 및 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

제1부 서론·조사 방법·조사 범위

제2부 개요

제1장 시장 개요

  • 세계 경쟁사의 시장 점유율
  • 경쟁사의 시장 점유율 시나리오
  • Covid-19의 영향과 다가오는 세계의 경기후퇴

제2장 주요 기업

제3장 시장 동향·촉진요인

제4장 세계 시장 전망

제3부 시장 분석

  • 지역별 시장 분석
  • 미국
    • 시장 데이터
    • 미국 시장 점유율 : 기업별
    • 시장 분석
  • 캐나다
  • 일본
  • 중국
  • 유럽
    • 시장 데이터
    • 경쟁사의 시장 점유율 시나리오
    • 시장 분석
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타

제4부 경쟁

  • 기업 개요
KSA 20.06.19

Abstract:

Global Virus Filtration Products Market to Reach US$6.6 Billion by the Year 2026

Virus filtration is a non-destructive, easy, and effective method of maintaining non-enveloped and enveloped virus particles within or on the surface of polymeric membrane pores. Growth in the global market is set to be driven by extensive demand from biotechnology and biopharmaceutical industries. These industries make extensive usage of virus filtration products for protecting their products from any kind of contamination. Other growth boosting factors include favorable regulations, better funding, as well as support to various R&D projects by both private enterprises and government. Increasing investment and focus on research has boosted development of innovative technologies that facilitate manufacturing of novel filtration products capable of filtering minute structures ranging from microorganisms like viruses and bacteria to particles. Growing usage of biotherapeutics has boosted R&D as well as formulation of novel drugs extracted from different natural sources for treatment of an array of chronic disorders. The rising incidence of various diseases and chronic conditions around the world, combined with stringent regulations regarding virus-free therapeutics is likely to propel the virus-filtration industry over the medium-term. Focus on development of high-tech products, supportive government regulations, and launch of novel products is expected to benefit market growth.

Amid the COVID-19 crisis, the global market for Virus Filtration Products estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2026, growing at a CAGR of 13.1% over the analysis period. Kits & Reagents, one of the segments analyzed in the report, is projected to grow at a 14.7% CAGR to reach US$4.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Filtration Systems segment is readjusted to a revised 11% CAGR for the next 7-year period. This segment currently accounts for a 23.9% share of the global Virus Filtration Products market.

The U.S. Market is Estimated at $1.1 Billion in 2021, While China is Forecast to Reach $899.5 Million by 2026

The Virus Filtration Products market in the U.S. is estimated at US$1.1 Billion in the year 2021. The country currently accounts for a 31.98% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$899.5 Million in the year 2026 trailing a CAGR of 16.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 11.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR while Rest of European market (as defined in the study) will reach US$322.9 Million by the end of the analysis period. The virus filtration market is dominated by North America owing to growth in industrialization, patient awareness, presence of modern infrastructure, as well as high per capita expenditure on healthcare. The European market benefits from favorable policies by the government with respect to healthcare infrastructure. Growth in Asia-Pacific region is due to increased demand for high-quality therapeutics in large countries such as China and India. In developing countries like China and India, robust economic growth is supporting biotechnology and pharmaceutical units.

Filtration Systems Segment to Reach $1.4 Billion by 2026

A considerable portion of the growth for virus filtration comes from the biopharmaceutical sector. Amidst the rise in single use filtration products and stringent quality standards, the biopharmaceutical sector is expected to expand the market for membrane technology in the near future. In the global Filtration Systems segment, USA, Canada, Japan, China and Europe will drive the 10.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$570.8 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$150.6 Million by the year 2026, while Latin America will expand at a 11.9% CAGR through the analysis period.

Select Competitors (Total 41 Featured) -

  • Asahi Kasei Medical Co., Ltd.
  • Charles River Laboratories International, Inc.
  • General Electric Company
  • Lonza Group AG
  • Merck KgaA
  • MilliporeSigma
  • Pall Corporation
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Virus Filtration Membranes
    • A Prelude to Virus Filtration
    • Virus Filtration in Biopharmaceuticals
    • Enhanced mAb Concentration
    • Impact of Covid-19 and a Looming Global Recession
    • 2020: A Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19 Impact on Virus Filtration Market
    • Global Market Prospects and Outlook
    • Virus Filtration Market Set for a Rapid Growth
    • Segment Analysis
    • Developed Regions Dominate, Developing to Witness Fastest Growth
    • Market Challenges
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • An Expanding Biopharmaceuticals Sector Drives Growth Opportunities
    • EXHIBIT 2: Global Biopharmaceuticals Market: Revenues in US$ Billion for the Years 2019, 2021, 2023 and 2025
    • EXHIBIT 3: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Pharmaceutical industry Opens Growth Avenues for Virus Filtration
    • EXHIBIT 4: Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
    • Advanced Virus Filters in the Pharmaceutical Industry
    • Filtration Technological Advancements Drive Market Growth
    • Filtration using Adsorption
    • Filtration Advancements
    • Mask Tracking and Tracing
    • Demographic Trends & Growing Incidence of Chronic Diseases to Push the Market Ahead
    • EXHIBIT 5: Global Population Statistics for the 60+ Age Group by Geographic Region: 2019
    • EXHIBIT 6: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 7: World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Expansion of Single-Use Technologies in Virus Filtration Products
    • Virus Filtration for Biopharmaceutical Production
    • The Advent of Continuous Process Methods Drives Market Growth
    • Parvovirus Filtration Registers Steady Growth
    • Virus Retentive Filters Witness Rapid Growth
    • New Air Filters to Fight Against COVID-19
    • Manufacturers Show Virus Filtration Safety Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Virus Filtration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Virus Filtration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Virus Filtration Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
    • TABLE 4: World Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 7: World Current & Future Analysis for Filtration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Filtration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Filtration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 10: World Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 13: World Current & Future Analysis for Biologicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Biologicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Biologicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 16: World Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 19: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 22: World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 25: World Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 28: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 31: USA Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 34: USA Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 37: USA Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • CANADA
    • TABLE 40: Canada Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 43: Canada Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 46: Canada Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • JAPAN
    • TABLE 49: Japan Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 52: Japan Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 55: Japan Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • CHINA
    • TABLE 58: China Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 61: China Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 64: China Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • EUROPE
    • TABLE 67: Europe Current & Future Analysis for Virus Filtration Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Virus Filtration Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Virus Filtration Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
    • TABLE 70: Europe Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 73: Europe Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 76: Europe Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • FRANCE
    • TABLE 79: France Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 82: France Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 85: France Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • GERMANY
    • TABLE 88: Germany Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 91: Germany Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 94: Germany Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ITALY
    • TABLE 97: Italy Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 100: Italy Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 103: Italy Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 106: UK Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 109: UK Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 112: UK Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • SPAIN
    • TABLE 115: Spain Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Spain 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 118: Spain Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 121: Spain Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Spain Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Spain 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • RUSSIA
    • TABLE 124: Russia Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Russia 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 127: Russia Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 130: Russia Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Russia Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Russia 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF EUROPE
    • TABLE 133: Rest of Europe Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 139: Rest of Europe Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of Europe Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of Europe 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ASIA-PACIFIC
    • TABLE 142: Asia-Pacific Current & Future Analysis for Virus Filtration Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Virus Filtration Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Virus Filtration Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Asia-Pacific Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Asia-Pacific 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • AUSTRALIA
    • TABLE 154: Australia Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Australia 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 157: Australia Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 160: Australia Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Australia Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Australia 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • INDIA
    • TABLE 163: India Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: India 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 166: India Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 169: India Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: India Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: India 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • SOUTH KOREA
    • TABLE 172: South Korea Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: South Korea 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 178: South Korea Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: South Korea Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: South Korea 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 187: Rest of Asia-Pacific Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of Asia-Pacific Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • LATIN AMERICA
    • TABLE 190: Latin America Current & Future Analysis for Virus Filtration Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Virus Filtration Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Latin America 15-Year Perspective for Virus Filtration Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 199: Latin America Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Latin America Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Latin America 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ARGENTINA
    • TABLE 202: Argentina Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Argentina Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Argentina 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Argentina 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 208: Argentina Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Argentina Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Argentina 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • BRAZIL
    • TABLE 211: Brazil Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Brazil Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Brazil 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Brazil 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 217: Brazil Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Brazil Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Brazil 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • MEXICO
    • TABLE 220: Mexico Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Mexico Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Mexico 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Mexico 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 226: Mexico Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Mexico Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Mexico 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF LATIN AMERICA
    • TABLE 229: Rest of Latin America Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Latin America Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Rest of Latin America 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 235: Rest of Latin America Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Rest of Latin America Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Rest of Latin America 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • MIDDLE EAST
    • TABLE 238: Middle East Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Middle East Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Middle East 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • AFRICA
    • TABLE 247: Africa Current & Future Analysis for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Africa Historic Review for Virus Filtration Products by Product - Kits & Reagents, Filtration Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Africa 15-Year Perspective for Virus Filtration Products by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Filtration Systems and Other Products for the Years 2012, 2021 & 2027
    • TABLE 250: Africa Current & Future Analysis for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Africa Historic Review for Virus Filtration Products by Application - Biologicals, Medical Devices and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Africa 15-Year Perspective for Virus Filtration Products by Application - Percentage Breakdown of Value Sales for Biologicals, Medical Devices and Other Applications for the Years 2012, 2021 & 2027
    • TABLE 253: Africa Current & Future Analysis for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Africa Historic Review for Virus Filtration Products by End-Use - Pharma & Biotech Companies, Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Africa 15-Year Perspective for Virus Filtration Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 41
Back to Top
전화 문의
F A Q